The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.

Documenti analoghi

• The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.
  di: Liou, H C, et al.
  Pubblicazione: (1992)
• The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.
  di: Naumann, M, et al.
  Pubblicazione: (1993)
• Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.
  di: Watanabe, N, et al.
  Pubblicazione: (1997)
• NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
  di: Heissmeyer, V, et al.
  Pubblicazione: (1999)
• The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
  di: Franzoso, G, et al.
  Pubblicazione: (1993)